Events › B2B Event
B2B Event
The ASH Meeting on Hematologic Malignancies focuses on advancing the treatment of blood cancers, bringing together experts in hematology to discuss the latest science and clinical data. It is a key meeting for industry partners involved in leukemia, lymphoma, and myeloma research.
Filter this event to your ICP.
Hundreds of exhibitors here. You probably care about 20–30. Tell us your ICP, we'll find them.
Request intelligence →Delivery within 24 hours · $1,250
⚠️ The exhibitor list for this event isn't publicly accessible yet. We'll work on it once you submit a request.
Why people attend
Healthcare professionals attend to hear late-breaking science and interact with industry partners in an intimate, focused environment compared to the massive Annual Meeting.
Exhibitor categories
Sample matches
Filtered to a Series-B SaaS ICP. Your filter will be different.
Sample Match A
example.com
"Strong ICP match: Series B, EU expansion, VP Engineering and CTO attending."
Sample Match B
example.io
"Mid-stage SaaS with active GTM motion; product-led growth signals align with ICP."
████████ ██████
████████.io
"████████████████████████████████████████."
Submit your ICP
to unlock all matches
████████ ██████
████████.io
"████████████████████████████████████████."
Submit your ICP
to unlock all matches
More B2B Event events
More events in United States
Frequently asked questions